ADVERTISEMENTREMOVE AD
Members Only
lock close icon

Covishield vs Covaxin vs Sputnik: BC Aunty’s Class of Vaccines

BC Aunty evaluates the performance of vaccines available across the world.

Published
Now Rolling
1 min read
Aa
Aa
Small
Aa
Medium
Aa
Large

In March 2021, Bharat Biotech said that the results of its Phase 3 clinical trials had shown that the interim clinical efficacy of ‘Covaxin’ is 81 percent. While that’s an impressive number, the question is, where are the vaccines?

Even the world’s largest vaccine maker, Serum Institute of India, has been under tremendous pressure to meet local and international demands as the country battles the world’s worst surge in COVID-19 cases. As a result, many states have suspended the vaccination drive for 18-44 year olds due to vaccine shortage.

ADVERTISEMENTREMOVE AD

Now with the entry of the third vaccine, Sputnik V, developed by Russia’s Gamaleya National Center, let’s hope India meets its target of vaccinating the entire country by December 2021. For now, let’s evaluate the efficacy and effectiveness of COVID-19 vaccines available in India and abroad. Watch this video featuring BC Aunty aka Snehil Dexit Mehra for more.

Performer: Snehil Dixit Mehra
Script: Divya Talwar

(At The Quint, we are answerable only to our audience. Play an active role in shaping our journalism by becoming a member. Because the truth is worth it.)

0

Read Latest News and Breaking News at The Quint, browse for more from neon and now-rolling

Speaking truth to power requires allies like you.
Become a Member
3 months
12 months
12 months
Check Member Benefits
Read More
×
×